Literature DB >> 64254

Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL).

P Hilgard, H Schulte, G Wetzig, G Schmitt, C G Schmidt.   

Abstract

The effects of long-term anticoagulation with phenprocoumon on growth of the Lewis lung carcinoma (3LL) were studied. Oral anticoagulation initiated at the day of i.m. transplantation of the 3LL into C57BL mice significantly inhibited primary tumour growth and reduced the number of spontaneous metastases to the lungs. Intermittent anticoagulation was without effect on metastasis formation but still retarded primary growth. There was no influence of anticoagulation on the mean survival time (MST) of tumour-bearing animals. Phenprocoumon appears to improve the results of cyclophosphamide of 5-fluorouracil treatment, but there were no statisticially significant differences. In contrast, bleomycin treatment in combination with adjuvant anticoagulation suggested a possible drug synergy. No significant influence of anticoagulation on the response of the primary tumour to irradiattion was found, though the MST of irradiated and anticoagulated animals was greater than in the solely irradiated controls. The present investigations suggest that coumarin derivatives have some direct tumour-inhibiting capacities, but exert their antimetastatic action via deceleration of the blood clotting mechanism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64254      PMCID: PMC2025311          DOI: 10.1038/bjc.1977.6

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Cytological observations on carcinoma.

Authors:  R A O'MEARA; R D JACKSON
Journal:  Ir J Med Sci       Date:  1958-07       Impact factor: 1.568

2.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

3.  A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases.

Authors:  J M Brown
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

4.  The effect of heparin on the initial phase of metastasis formation.

Authors:  P Hilgard; L Beyerle; R Hohage; V Hiemeyer; M Kübler
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

5.  Inhibition of locomotion of cancer cells in vivo by anticoagulant therapy. I. Effects of sodium warfarin on V2 cancer cells, granulocytes, lymphocytes and macrophages in rabbits.

Authors:  R D Thornes; D W Edlow; S Wood
Journal:  Johns Hopkins Med J       Date:  1968-12

6.  Experimental tumour metastases and blood coagulability.

Authors:  B Hagmar
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1970
  6 in total
  12 in total

1.  Tissue procoagulant activity may be important in sustaining metastatic tumour growth.

Authors:  N J Carty; I Taylor; O S Roath; K el-Baruni; J L Francis
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Aggregation of activated platelets with Walker 256 carcinoma cells.

Authors:  W Paschen; H Patscheke; P Wörner
Journal:  Blut       Date:  1979-01-22

Review 3.  Post-translational carboxylation of preprothrombin.

Authors:  B C Johnson
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

4.  Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

Authors:  I A Lampert; P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

5.  Failure of orally administered RA233 to influence B16 melanoma growth or metastasis.

Authors:  C W Stackpole; D M Fornabaio; A L Alterman
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

6.  Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.

Authors:  B Maat; P Hilgard
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Factor X-activating activity from Lewis lung carcinoma.

Authors:  P Hilgard; P Whur
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

8.  Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth.

Authors:  P McCulloch; W D George
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

9.  Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.

Authors:  P McCulloch; W D George
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

10.  Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.

Authors:  A D Purushotham; P McCulloch; W D George
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.